![Erik Berglund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Erik Berglund formerly worked at Gilead Sciences, Inc., as Senior Director-Regulatory Affairs and Vistagen Therapeutics, Inc., as Senior Vice President-Global Regulatory Affairs from 2021 to 2025.
Dr. Berglund received his doctorate degree from Umea Universitet.
Precedenti posizioni note di Erik Berglund
| Società | Posizione | Fine |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Consigliere Generale | 10/01/2025 |
| GILEAD SCIENCES, INC. | Consigliere Generale | - |
Formazione di Erik Berglund
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
